Lipid nanoparticle‐mediated delivery of IL‐21‐encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence
Journal of Medical Virology · 2023-09 · 95 (9)
DOI: 10.1002/jmv.29062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 04.09.2023. Verfasst von Zhongliang Shen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, National Medical Center for Infec…. Hauptthemen laut MEDLINE: Hepatitis B virus, Leukocytes, Mononuclear. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hepatitis B virus (HBV) covalently closed circular DNA (cccDNA), the transcription template for all viral mRNAs, is highly stable and current treatment options cannot effectively induce its clearance. Previously, we established an HBV persistence mouse model based on a clinical isolate (termed BPS) and identified interleukin‐21 (IL‐21) as a potent inducer of HBV clearance. Lipid nanoparticle (LNP) mediated delivery of mRNA has proven to be a highly safe and effective delivery platform. This work explored the applicability and effectiveness of the mRNA‐LNP platform in IL‐21‐based HBV therapies. First, LNP‐encapsulated murine IL‐21 mRNA (LNP‐IL‐21) was prepared, characterized, and demonstrated to engender IL‐21 expression in vitro and in vivo. Next, LNP‐IL‐21 was shown to induce clearance of both serum and intrahepatic HBV antigen and DNA in two HBV persistence mouse models based on BPS and recombinant cccDNA (rcccDNA), respectively, which was associated with HBV‐specific humoral and cellular immune responses. Furthermore, peripheral blood mononuclear cells from BPS persistence mice treated ex vivo with LNP‐IL‐21 and HBV surface antigen (HBsAg) could induce similar HBV clearance upon infusion into recipient mice. These findings indicated that IL‐21 combined with mRNA‐LNP platform represents a valid and promising strategy for developing novel therapeutics against chronic HBV infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, Department of Infectious Diseases, National Medical Center for Infectious Diseases, Shanghai Institute of Infectious Diseases and Biosecur…
- Key Laboratory of Medical Molecular Virology (Ministry of Education/National Health Commission/Chinese Academy of Medical Sciences), Department of Microbiology and Parasitology, School of Basic Medical Sciences, Shangha…
- School of Materials and Chemistry, University of Shanghai for Science and Technology, Shanghai, China.
- Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
- Children's Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Zhongliang Shen, Qirong Jiang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Shen, Z., Zhang, S., Jiang, Q., Liu, N., Li, F., Gao, Z., Pan, S., Hao, W., Deng, Q., Liu, J., Zhang, J., & Xie, Y. (2023). Lipid nanoparticle‐mediated delivery of IL‐21‐encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence. Journal of Medical Virology, 95(9). https://doi.org/10.1002/jmv.29062
Vancouver
Shen Z, Zhang S, Jiang Q, Liu N, Li F, Gao Z, et al. Lipid nanoparticle‐mediated delivery of IL‐21‐encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence. Journal of Medical Virology. 2023;95(9). doi:10.1002/jmv.29062
BibTeX
@article{Shen2023,
author = {Shen, Zhongliang and Zhang, Shenyan and Jiang, Qirong and Liu, Nannan and Li, Fahong and Gao, Zixiang and Pan, Shaokun and Hao, Weiju and Deng, Qiang and Liu, Jing and Zhang, Jiming and Xie, Youhua},
title = {Lipid nanoparticle‐mediated delivery of IL‐21‐encoding mRNA induces viral clearance in mouse models of hepatitis B virus persistence},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {9},
doi = {10.1002/jmv.29062}
}
EUVIMED